McAdam LLC’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

McAdam LLC’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-725	Closed	-$12K	–	665
2018 Q3	$12K	Sell	725 -725	-50%	-$15.7K	﹤0.01%	322
2018 Q2	$30K	Buy	+1,450	New	+$26.9K	0.01%	195

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

McAdam LLC's SPPI Position: Q4 2018 in Review

McAdam LLC sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2018, closing a stake of 725 shares — an estimated $12K sold.

McAdam LLC first reported a position in SPPI in Q2 2018 and held it in 2 quarters. The position peaked at $30K in Q2 2018. 176 funds tracked by Wall St. Rank hold SPPI as of Q4 2018.

McAdam LLC reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
McAdam LLC sold 725 Spectrum Pharmaceuticals Inc shares in Q4 2018, an estimated $12K.
McAdam LLC first reported a position in Spectrum Pharmaceuticals Inc in Q2 2018 and held it in 2 quarters.
McAdam LLC's Spectrum Pharmaceuticals Inc position peaked at $30K in Q2 2018.
176 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2018.

Based on McAdam LLC's 13F filing for Q4 2018, filed 30 Jan 2019.